San Francisco, CA, United States of America

Daniel Almonacid

This inventor holds 90 USPTO granted patents and 33 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Microbiome Diagnostics (CPC class G06F19-3418). Top assignees: Ubiome, Inc., Psomagen, Inc., Macrogen Corp.. Active years: 2017-2026.

USPTO Granted Patents = 90 (Patent Applications = 33)

% Patents Active = 98.9

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 46)

Average Co-Inventor Count = 3.6

ph-index = 9

Forward Citations = 289(Granted Patents)

Forward Citations (Not Self Cited) = 155(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

4. 1 out of 834,411

Other

patents

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Microbiome

Diagnostics

Therapeutics

CRISPR

Allergy Treatments

Nucleic Acid Sequencing

Bacterial Vaginosis

Mental Health

Pharmacogenomics

Trimethylamine

Reproductive Health

Infectious Disease

90 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12576123 - Epitope-Based Approach for Allergy Treatments and Inhibitors for Crohn's Disease (2026-03-17),

2. 12060599 - Method and system for microbiome-derived diagnostics and therapeutics for bacterial vaginosis (2024-08-13),

3. 11987841 - Single molecule sequencing and unique molecular identifiers to characterize nucleic acid sequences (2024-05-21),

4. 11931400 - Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof (2024-03-19),

5. 11783914 - Method and system for panel characterizations (2023-10-10),

6. 11773455 - Method and system for microbiome-derived diagnostics and therapeutics infectious disease and other health conditions associated with antibiotic usage (2023-10-03),

7. 11634703 - Method and system for high-throughput particle handling by use of magnetic fields and device (2023-04-25),

8. 11621055 - Microorganism-related significance index metrics (2023-04-04),

9. 11572555 - Method and system for CRISPR-based library preparation and sequencing (2023-02-07),

10. 11424006 - Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide (2022-08-23),

11. 11001900 - Method and system for characterization for female reproductive system-related conditions associated with microorganisms (2021-05-11),

12. 10902938 - Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions (2021-01-26),

13. 10803992 - Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions (2020-10-13),

14. 10803991 - Method and system for microbiome-derived diagnostics and therapeutics (2020-10-13),

15. 10803147 - Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions (2020-10-13),

Title: The Innovative Journey of Daniel Almonacid

Introduction: Daniel Almonacid, a talented inventor based in San Francisco, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Daniel Almonacid holds several patents in the field of artificial intelligence and renewable energy technologies, showcasing his commitment to creating sustainable solutions for the future.

Career Highlights: With a background in engineering and a passion for problem-solving, Daniel Almonacid has successfully brought several of his inventions from concept to market, revolutionizing industries along the way.

Collaborations: Throughout his career, Daniel Almonacid has collaborated with leading research institutions and tech companies to further develop his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Daniel Almonacid's dedication to innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.